Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Faster Results Remedy members lose weight twice as fast as the industry average within 90 days
Diagnosis is made by measuring the concentration of different metabolites in the -glutamyl cycle and homocysteine, enzyme activity, and/or mutation analysis
Retatrutide is an investigational GLP-1/GIP/glucagon triple receptor agonist with no MHRA or EMA marketing authorisation
What Patients Should Know About Retatrutide Retatrutide is an investigational weight-loss medicine and is not FDA-approved
Going from 2 mg directly to 8 mg, or from 4 mg to 12 mg, dramatically increases the risk of severe gastrointestinal events and potential complications
US$ 23.88
US$ 22.34
